comparemela.com

Xiling Lab Pharmaceutical Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IPO Update: Intrinsic Medicine Aims For $25 Million IPO (Pending:INRX)

Intrinsic Medicine has filed proposed terms for a $25M U.S. IPO. It develops treatments for GBA & inflammatory diseases. See why I'm on Hold for INRX stock.

United statesGrand viewEvelo biosciencesAlexander martinezXiling lab pharmaceutical coEuropean patent officeIronwood pharmaceuticalsSalix pharmaceuticalsBoston pharmaceuticalsFinch therapeutics groupSebela pharmaceuticalsCompany technologiesView researchArena pharmaceuticalsDrug development pipelineCorporate development of ionis

Intrinsic Medicine Seeks U S IPO For IBS Treatments

Intrinsic Medicine has filed to raise investment via IPO. The firm is developing treatments for irritable bowel syndrome variants. Read more on INRX stock here.

United statesGrand viewEvelo biosciencesAlexander martinezEuropean patent officeCompany technologyIronwood pharmaceuticalsView researchArena pharmaceuticalsCorporate development of ionisSebella pharmaceuticalsXiling lab pharmaceutical coDevelopment laboratoryTreatment market size grand view researchProfessionals doing research in advanced scientific labBoston pharmaceuticals

vimarsana © 2020. All Rights Reserved.